102 related articles for article (PubMed ID: 21440742)
1. Therapeutic drug monitoring in de novo kidney transplant receiving the modified-release once-daily tacrolimus.
Jelassi ML; Lefeuvre S; Karras A; Moulonguet L; Billaud EM
Transplant Proc; 2011 Mar; 43(2):491-4. PubMed ID: 21440742
[TBL] [Abstract][Full Text] [Related]
2. De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.
Crespo M; Mir M; Marin M; Hurtado S; Estadella C; Gurí X; Rap O; Moral R; Puig JM; Lloveras J
Transplant Proc; 2009; 41(6):2115-7. PubMed ID: 19715848
[TBL] [Abstract][Full Text] [Related]
3. First clinical experience with the new once-daily formulation of tacrolimus.
First MR
Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
5. Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.
Hougardy JM; Broeders N; Kianda M; Massart A; Madhoun P; Le Moine A; Hoang AD; Mikhalski D; Wissing KM; Abramowicz D
Transplantation; 2011 Mar; 91(5):566-9. PubMed ID: 21192316
[TBL] [Abstract][Full Text] [Related]
6. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
7. The once-daily formulation of tacrolimus: a step forward in kidney transplantation?
Hougardy JM; de Jonge H; Kuypers D; Abramowicz D
Transplantation; 2012 Feb; 93(3):241-3. PubMed ID: 22234346
[TBL] [Abstract][Full Text] [Related]
8. Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation.
Iaria G; Sforza D; Angelico R; Toti L; de Luca L; Manuelli M; Bellini I; Manzia TM; Anselmo A; Tisone G
Transplant Proc; 2011 May; 43(4):1028-9. PubMed ID: 21620043
[TBL] [Abstract][Full Text] [Related]
9. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
10. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
Ma MK; Kwan LP; Mok MM; Yap DY; Tang CS; Chan TM
Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P
Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850
[TBL] [Abstract][Full Text] [Related]
12. Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.
Meçule A; Poli L; Nofroni I; Bachetoni A; Tinti F; Umbro I; Barile M; Berloco PB; Mitterhofer AP
Transplant Proc; 2010 May; 42(4):1317-9. PubMed ID: 20534290
[TBL] [Abstract][Full Text] [Related]
13. Early conversion from twice-daily tacrolimus to once-daily extended formulation in renal transplant patients before hospital discharge.
Jannot M; Masson I; Alamartine E; Mariat C
Ann Transplant; 2014 Jul; 19():320-4. PubMed ID: 24999809
[TBL] [Abstract][Full Text] [Related]
14. Four-year experience with tacrolimus once-daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies.
van Hooff JP; Alloway RR; Trunečka P; Mourad M
Clin Transplant; 2011; 25(1):E1-12. PubMed ID: 21158926
[TBL] [Abstract][Full Text] [Related]
15. Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation.
Calia R; Lai C; Aceto P; Luciani M; Romagnoli J; Lai S; Gargiulo A; Citterio F
Transplant Proc; 2011 May; 43(4):1020-3. PubMed ID: 21620041
[TBL] [Abstract][Full Text] [Related]
16. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants.
Almeida-Paulo GN; Lubomirov R; Alonso-Sanchez NL; Espinosa-Román L; Fernández Camblor C; Díaz C; Muñoz Bartola G; Carcas-Sansuán AJ
Transpl Int; 2014 Sep; 27(9):939-48. PubMed ID: 24861353
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Staatz CE; Willis C; Taylor PJ; Tett SE
Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
[TBL] [Abstract][Full Text] [Related]
18. Conversion to tacrolimus extended-release formulation: short-term clinical results.
Gallego-Valcarce E; Ortega-Cerrato A; Llamas-Fuentes F; Martinez-Fernandez G; Perez-Martinez J; Gomez-Roldan C
Transplant Proc; 2009; 41(6):2326-7. PubMed ID: 19715909
[TBL] [Abstract][Full Text] [Related]
19. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
Comuzzi C; Lorenzin D; Rossetto A; Faraci MG; Nicolini D; Garelli P; Bresadola V; Toniutto P; Soardo G; Baroni GS; Adani GL; Risaliti A; Baccarani U
Transplant Proc; 2010 May; 42(4):1320-1. PubMed ID: 20534291
[TBL] [Abstract][Full Text] [Related]
20. Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients.
Wu MJ; Cheng CY; Chen CH; Wu WP; Cheng CH; Yu DM; Chuang YW; Shu KH
Transplantation; 2011 Sep; 92(6):648-52. PubMed ID: 21912349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
